Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Biomolecules ; 11(12)2021 12 16.
Artigo em Inglês | MEDLINE | ID: mdl-34944533

RESUMO

Fermented persimmon juice, Kakishibu, has traditionally been used for wood and paper protection. This protective effect stems at least partially from inhibition of microbial cellulose degrading enzymes. The inhibitory effect of Kakishibu on lytic polysaccharide monooxygenases (LPMOs) and on a cocktail of cellulose hydrolases was studied, using three different cellulosic substrates. Dose dependent inhibition of LPMO activity by a commercial Kakishibu product was assessed for the well-characterized LPMO from Thermoascus aurantiacus TaAA9A, and the inhibitory effect was confirmed on five additional microbial LPMOs. The model tannin compound, tannic acid exhibited a similar inhibitory effect on TaAA9A as Kakishibu. It was further shown that both polyethylene glycol and tannase can alleviate the inhibitory effect of Kakishibu and tannic acid, indicating a likely mechanism of inhibition caused by unspecific tannin-protein interactions.


Assuntos
Diospyros/química , Inibidores Enzimáticos/farmacologia , Sucos de Frutas e Vegetais/microbiologia , Oxigenases de Função Mista/antagonistas & inibidores , Thermoascus/enzimologia , Hidrolases de Éster Carboxílico/efeitos adversos , Diospyros/microbiologia , Relação Dose-Resposta a Droga , Inibidores Enzimáticos/química , Fermentação , Sucos de Frutas e Vegetais/análise , Proteínas Fúngicas/antagonistas & inibidores , Regulação Fúngica da Expressão Gênica/efeitos dos fármacos , Hidrolases/antagonistas & inibidores , Polietilenoglicóis/efeitos adversos , Taninos/farmacologia , Thermoascus/efeitos dos fármacos
2.
Cells ; 9(8)2020 07 27.
Artigo em Inglês | MEDLINE | ID: mdl-32726939

RESUMO

Recessive mutations in Post-GPI attachment to proteins 3 (PGAP3) cause the rare neurological disorder hyperphosphatasia with mental retardation syndrome 4 type (HPMRS4). Here, we report a novel homozygous nonsense mutation in PGAP3 (c.265C>T-p.Gln89*), in a 3-year-old boy with unique novel clinical features. These include decreased intrauterine fetal movements, dysgenesis of the corpus callosum, olfactory bulb agenesis, dysmorphic features, cleft palate, left ear constriction, global developmental delay, and hypotonia. The zebrafish functional modeling of PGAP3 loss resulted in HPMRS4-like features, including structural brain abnormalities, dysmorphic cranial and facial features, hypotonia, and seizure-like behavior. Remarkably, morphants displayed defective neural tube formation during the early stages of nervous system development, affecting brain morphogenesis. The significant aberrant midbrain and hindbrain formation demonstrated by separation of the left and right tectal ventricles, defects in the cerebellar corpus, and caudal hindbrain formation disrupted oligodendrocytes expression leading to shorter motor neurons axons. Assessment of zebrafish neuromuscular responses revealed epileptic-like movements at early development, followed by seizure-like behavior, loss of touch response, and hypotonia, mimicking the clinical phenotype human patients. Altogether, we report a novel pathogenic PGAP3 variant associated with unique phenotypic hallmarks, which may be related to the gene's novel role in brain morphogenesis and neuronal wiring.


Assuntos
Anormalidades Múltiplas/genética , Encéfalo/patologia , Hidrolases de Éster Carboxílico/efeitos adversos , Deficiência Intelectual/genética , Distúrbios do Metabolismo do Fósforo/genética , Anormalidades Múltiplas/metabolismo , Animais , Modelos Animais de Doenças , Humanos , Deficiência Intelectual/metabolismo , Morfogênese , Distúrbios do Metabolismo do Fósforo/metabolismo , Receptores de Superfície Celular , Peixe-Zebra
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA